Bengaluru, India

Malatesh Patil

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Heil Co.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Malatesh Patil in Refuse Vehicle Assembly

Introduction

Malatesh Patil is an accomplished inventor based in Bengaluru, India. He has made significant contributions to the field of refuse vehicle assembly, showcasing his innovative spirit through his patented methods and devices.

Latest Patents

Malatesh Patil holds a patent for "Methods and devices for assembling refuse vehicles." This patent describes a method of assembling a refuse vehicle that includes coupling body sub-assemblies to one another on a chassis after the sub-assemblies are painted. The body sub-assemblies are constructed from refuse vehicle body components, and each sub-assembly is painted independently of the others. Once painted, the sub-assemblies are assembled onto the chassis to create a complete painted body for the refuse vehicle.

Career Highlights

Malatesh Patil is currently employed at The Heil Co., where he continues to develop innovative solutions in the refuse vehicle industry. His work has contributed to advancements in vehicle assembly techniques, enhancing efficiency and quality in production.

Collaborations

Throughout his career, Malatesh has collaborated with notable colleagues, including Mark Fraas and Eric Dale Hughes. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Malatesh Patil's innovative approach to refuse vehicle assembly exemplifies the impact of creativity in engineering. His patent and contributions to The Heil Co. highlight the importance of innovation in improving industry standards.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…